| 1. Executive Summary |
| 2. Global Cardiac Markers Market Introduction |
| 2.1. Global Cardiac Markers Market – Taxonomy |
| 2.2. Global Cardiac Markers Market –Definitions |
| 2.2.1. By Test Type |
| 2.2.2. By Type of Testing |
| 2.2.3. By Region |
| 3. Global Cardiac Markers Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Cardiac Markers Market Dynamic Factors - Impact Analysis |
| 3.6. Global Cardiac Markers Market – Competition Landscape |
| 4. Global Cardiac Markers Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 |
| 4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Cardiac Markers Market, By Test Type, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.1. NT-proBNP Test |
| 5.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Troponin I & T |
| 5.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. GDF-15 |
| 5.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. hsCRP |
| 5.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Others |
| 5.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6. Global Cardiac Markers Market, By Type of Testing, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.1. Laboratory Testing |
| 6.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Point of Care Testing |
| 6.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7. Global Cardiac Markers Market Forecast, By Region, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia-Pacific |
| 7.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Latin America |
| 7.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Middle East and Africa |
| 7.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Global Cardiac Markers Market - Opportunity Analysis Index, By Test Type, Type of Testing, and Region, 2022 - 2028 |
| 8. North America Cardiac Markers Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.1. Test Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1. NT-proBNP Test |
| 8.1.2. Troponin I & T |
| 8.1.3. GDF-15 |
| 8.1.4. CK-MB |
| 8.1.5. hsCRP |
| 8.1.6. Others |
| 8.2. Type of Testing Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 8.2.1. Laboratory Testing |
| 8.2.2. Point of Care Testing |
| 8.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 8.3.1. USA |
| 8.3.2. Canada |
| 8.4. North America Cardiac Markers Market - Opportunity Analysis Index, By Test Type, Type of Testing, and Country, 2022 - 2028 |
| 8.5. North America Cardiac Markers Market Dynamics – Trends |
| 9. Europe Cardiac Markers Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 9.1. Test Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. NT-proBNP Test |
| 9.1.2. Troponin I & T |
| 9.1.3. GDF-15 |
| 9.1.4. CK-MB |
| 9.1.5. hsCRP |
| 9.1.6. Others |
| 9.2. Type of Testing Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.2.1. Laboratory Testing |
| 9.2.2. Point of Care Testing |
| 9.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Germany |
| 9.3.2. UK |
| 9.3.3. France |
| 9.3.4. Spain |
| 9.3.5. Italy |
| 9.3.6. Russia |
| 9.3.7. Rest of Europe |
| 9.4. Europe Cardiac Markers Market - Opportunity Analysis Index, By Test Type, Type of Testing, and Country, 2022 - 2028 |
| 9.5. Europe Cardiac Markers Market Dynamics – Trends |
| 10. Asia-Pacific Cardiac Markers Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 10.1. Test Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. NT-proBNP Test |
| 10.1.2. Troponin I & T |
| 10.1.3. GDF-15 |
| 10.1.4. CK-MB |
| 10.1.5. hsCRP |
| 10.1.6. Others |
| 10.2. Type of Testing Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Laboratory Testing |
| 10.2.2. Point of Care Testing |
| 10.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Japan |
| 10.3.2. China |
| 10.3.3. India |
| 10.3.4. ASEAN |
| 10.3.5. Australia & New Zealand |
| 10.3.6. Rest of Asia-Pacific |
| 10.4. Asia-Pacific Cardiac Markers Market - Opportunity Analysis Index, By Test Type, Type of Testing, and Country, 2022 - 2028 |
| 10.5. Asia-Pacific Cardiac Markers Market Dynamics – Trends |
| 11. Latin America Cardiac Markers Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 11.1. Test Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. NT-proBNP Test |
| 11.1.2. Troponin I & T |
| 11.1.3. GDF-15 |
| 11.1.4. CK-MB |
| 11.1.5. hsCRP |
| 11.1.6. Others |
| 11.2. Type of Testing Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Laboratory Testing |
| 11.2.2. Point of Care Testing |
| 11.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Brazil |
| 11.3.2. Mexico |
| 11.3.3. Argentina |
| 11.3.4. Rest of Latin America |
| 11.4. Latin America Cardiac Markers Market - Opportunity Analysis Index, By Test Type, Type of Testing, and Country, 2022 - 2028 |
| 11.5. Latin America Cardiac Markers Market Dynamics – Trends |
| 12. Middle East and Africa Cardiac Markers Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 12.1. Test Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. NT-proBNP Test |
| 12.1.2. Troponin I & T |
| 12.1.3. GDF-15 |
| 12.1.4. CK-MB |
| 12.1.5. hsCRP |
| 12.1.6. Others |
| 12.2. Type of Testing Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Laboratory Testing |
| 12.2.2. Point of Care Testing |
| 12.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Gulf Cooperation Council (GCC) Countries |
| 12.3.2. Israel |
| 12.3.3. South Africa |
| 12.3.4. Rest of MEA |
| 12.4. MEA Cardiac Markers Market - Opportunity Analysis Index, By Test Type, Type of Testing, and Country, 2022 - 2028 |
| 12.5. MEA Cardiac Markers Market Dynamics – Trends |
| 13. Competition Landscape |
| 13.1. Strategic Dashboard of Top Market Players |
| 13.2. Company Profiles (Introduction, Financial Analysis, Test Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 13.2.1. F. Hoffman-LA Roche |
| 13.2.2. Abbott Laboratories |
| 13.2.3. Siemens |
| 13.2.4. Danaher Corporation |
| 13.2.5. Biomerieux |
| 13.2.6. Ortho Clinical Diagnostics |
| 13.2.7. Randox Laboratories |
| 14. Research Methodology |
| 15. Key Assumptions and Acronyms |
hghNorth America Got Significant Share
Cardiac Markers Market
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Frequently Asked Questions
2021 is the base year and 2028 is the forecast year.
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
- Hoffman-LA Roche
- Abbott Laboratories
- Siemens
- Danaher Corporation
- Biomerieux
- Ortho Clinical Diagnostics
- Randox Laboratories